Key Takeaways

  • HPC raised A$392,000 via a placement of 98 million shares at A$0.004 each, alongside a proposed options issue that requires shareholder approval.
  • Founder and long-time CEO Oliver Baker stepped down on 15 June 2026, moving into a consultant role, with e-commerce lead Emily Lease appointed General Manager.
  • Non-Executive Chair Adem Karafili and director Joseph Constable resigned; George Karafotias and Nick Katiforis joined the board, and Nick Berry became Chair.
  • The board says the changes should cut annual cash costs by roughly A$500,000, including a reduction in board fees from about A$243,000 to A$120,000 a year.
  • HPC's shares were suspended from trading for several days in May 2026 over a late annual report lodgement, underscoring the operational strain facing this small-cap.

HPC agreed to place 98 million fully paid ordinary shares at A$0.004 each, raising A$392,000 before costs, as per 15 June announcement. The placement did not require shareholder approval and was expected to settle on 17 June 2026. Alongside it, the company proposed 49 million options on a one-for-two basis, exercisable at A$0.006 over a 36-month term — but this component needs shareholder sign-off, so it was not locked in at announcement date.

Management said proceeds would support "sales momentum from continuing US operations and consolidation of recent growth trends via established e-commerce channels" — working-capital support, not expansion capital.

The announcement confirmed that Non-Executive Chair Adem Karafili and Non-Executive Director Joseph Constable resigned, replaced by George Karafotias (a specialist in restructuring and turnaround strategies for ASX-listed companies), Nick Katiforis (a financial services professional with more than 20 years in capital markets), and Nick Berry (who moved into the Non-Executive Chair role). Founder and CEO Oliver Baker resigned effective 15 June 2026, moving into a consulting role, with Emily Lease appointed General Manager. Annual board remuneration will fall from approximately A$243,000 to A$120,000, with the company expecting overall annual cash expenses to fall by roughly A$500,000.

From a Multi-Market Brand to a US-Only Turnaround Story

HPC listed on the ASX in December 2021, raising around $17 million to fund expansion of its Hydralyte hydration products across North American retail. The most consequential change came in October 2024, when the company sold its non-US Hydralyte business and assets to Prestige Consumer Healthcare for approximately A$13.7 million — effectively converting HPC from an international brand owner into a single-market, US-focused hydration company.

HPC's FY24 results: revenue of US$3.2 million, down from US$4.3 million in FY23, with a net profit of US$2.67 million driven almost entirely by approximately US$8.2 million in accounting gains on the divestiture. Stripping out that one-off gain, the underlying operating loss from continuing US operations was US$5.67 million.

By the December 2025 quarter, HPC reported quarter-end cash of US$1.11 million, quarterly net sales of US$540,000 and operating cash outflow of US$619,000 — a smaller, leaner business than the one that listed in 2021, but still loss-making. In March 2025, HPC raised A$650,000 through a placement of 65 million shares, demonstrating that external capital support has been a recurring feature of the company's post-divestiture life.

Opportunities and Positive Factors

The clearest positive in the June 2026 announcement is the intent behind it: management and the board are explicitly targeting lower costs and a leaner cash-flow profile. A roughly A$500,000 annual reduction in cash costs is significant relative to a company with a market capitalisation of around A$2 million, and could shorten the distance to break-even if underlying US sales hold up.

The new directors bring relevant skill sets, with George Karafotias' focus on restructuring and turnarounds, and Nick Katiforis' two decades in capital markets, both pointing toward a board oriented around financial discipline and potential corporate transactions. Promoting Emily Lease, the incumbent e-commerce lead, to General Manager also suggests continuity in the parts of the business previously flagged as relative strengths.

HPC still owns a recognised hydration brand with placement in large US retail chains, including Shoppers Drug Mart, Rite Aid, Publix and H-E-B, and operates in a functional-hydration category that continues to attract consumer interest.

Risks and Uncertainties

HPC remains a loss-making company that has needed repeated small capital injections since divesting the bulk of its original international business in 2024. The June 2026 placement was modest — A$392,000 is small relative to recent quarterly cash burn rates — so further raisings, and further dilution, cannot be ruled out.

Leadership transitions of this scale carry execution risk: replacing a founder-CEO alongside a Chair and a director, all in one announcement, is a significant governance change to absorb at once. Emily Lease's prior e-commerce role provides some continuity, but she is stepping into general management for the first time.

The company's brief suspension from quotation in May 2026, tied to a late and initially non-compliant annual report, adds to a pattern of administrative friction. With a market capitalisation near A$2 million and a share price measured in tenths of a cent, HPC shares can move sharply on small trading volumes.

Catalysts — What to Watch Next

Confirmation of settlement of the placement and the outcome of the shareholder vote on the proposed options issue will show whether the full capital package proceeds. HPC's next quarterly Appendix 4C report will be the first hard test of whether the announced cost cuts are showing up in reduced cash burn, and whether US sales trends are continuing.

Statements from new Chair Nick Berry about "value accretive opportunities" leave open the possibility of a partnership, licensing arrangement or other corporate transaction, though nothing beyond that general language has been disclosed.

A Cautiously Balanced Conclusion

The 15 June 2026 announcement shows a small, financially stretched company doing what constrained micro-caps often do: raising a modest amount of capital, cutting costs, and refreshing leadership to buy time and sharpen focus. The verifiable facts — the A$392,000 placement, the roughly A$500,000 in annualised cost savings, and the wholesale change atop the board and executive team — are real and disclosed in HPC's own filings.

What remains unproven is whether this reset changes the underlying trajectory of the business. HPC has cut costs and raised small amounts of capital repeatedly since its 2021 listing without reaching sustainable profitability. Whether new leadership, a leaner cost base and continued US e-commerce momentum are enough to 'rehydrate growth' — or whether this is another chapter in an ongoing survival story — is a question the company's next few quarterly reports will need to answer.